Icon Group sign five-year deal to continue with Charm®

Icon Group has extended its relationship with Magentus, signing a new five-year contract for the continued use of the Charm oncology information management system.

This renewed agreement builds upon a successful initial contract signed in 2016, which has seen the implementation of Charm across all Integrated Icon Cancer Centre sites in Australia.

Charm empowers healthcare providers like Icon Group to streamline workflows, reduce treatment durations and wait times, and enhance patient care.

By digitising manual processes, the system supports adherence to best practice clinical guidelines and improves clinical safety by minimising transcription errors and enabling real-time adjustments to treatment plans based on patient needs.

Michele Blanshard, Magentus Managing Director (Practice Management & Oncology), said:

“Magentus is delighted to continue our partnership with Icon Group. By streamlining workflows and reducing administrative burdens, Charm empowers clinicians to focus on what matters most: providing exceptional patient care. The improved accuracy and timeliness of pharmacy orders and drug supply are also significant benefits of the Charm system.”

Rachael Powell, Magentus CEO, said:

“This renewed partnership with Icon Group underscores the growing importance of robust, interoperable oncology solutions. We are proud to support Icon Group in their mission to deliver exceptional cancer care and are committed to continually enhancing the system to meet evolving needs.”